¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-04

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-04
±³À°ÀÏÀÚ : 2021-09-04
±³À°Àå¼Ò : ¿Â¶óÀÎ ±³À°  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ-¿ÀÇÁ¶óÀÎ º´Çà)2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À°
ÁÖÃÖ±â°ü : ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ (ÀÌ»çÀåÁ¦)  
´ã´çÀÚ : °íÀº¾ç
¿¬¶ôó : 070-4888-5731  
À̸ÞÀÏ : ksbtp.svc@gmail.com      
±³À°Á¾·ù : Á¤½Å°Ç°­ÀÇÇаú      
Âü¼®¿¹»óÀοø : 150¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ºÎ»ê±¤¿ª½Ã
±³À°½Ã°£ : 13 ½Ã°£ 20ºÐ  
¼¼ºÎ¼ö°­·á : 40,000¿ø      
ºñ°í »çÀüµî·Ï-Àü¹®ÀÇ 40,000¿ø/±ºÀü¹®ÀÇ,°øº¸ÀÇ,Àü°øÀÇ 20,000¿ø/°£È£»ç,ÀÓ»ó½É¸®»ç,»çȸº¹Áö»ç 20,000¿ø/Æò»ýȸ¿ø-¸éÁ¦ÇöÀåµî·Ï-¾øÀ½      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ09:40~10:05 Development of a new therapeutic method to prevent neuronal inflammation using gut microbiota  Àå½ÂÈ£(¿ø±¤ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ10:05~10:30 Drug research through development of biomimetic system using 3D-neuronal spheroid  ÀÌÁ¤±¸(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ10:30~10:55 Clinical efficacy and safety of transcranial direct current stimulation (tDCS) in major depressive disorder through home clinical trials  À̱â¿ø(Ybrain) 
Åä·Ð 09-04 ¿Â¶óÀΠ10:55~11:05 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ11:15~11:40 New drugs expected to be effective in the treatment of schizophrenia and psychotic symptoms  À̺´´ë(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ11:40~12:05 Promising new drugs effective in the treatment of bipolar disorder  ¹®Àº¼ö(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ12:05~12:30 Promising drugs for the treatment of mental disorders in children and adolescents  ±è°æ¹Ì(ÀÎÁ¦ÀÇ´ë) 
Åä·Ð 09-04 ¿Â¶óÀΠ12:30~12:40 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ12:40~13:40 Reliable Long-term Management That prevents Recurrences and preserves Functioning through Long Acting Injectable Antipsychotics in Bipolar disorder  ÀÓÀº¼º(½Å¼¼°è È¿º´¿ø) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ14:00~14:25 How should we diagnose and treat fibromyalgia?  ±è¼ºÈ£(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ14:25~14:50 Chronic pain and sleep disorders  ¹æ¿µ·Õ(µ¿¾ÆÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ14:50~15:15 Antidepressants: another weapon against chronic pain  Àå¼¼Çå(ºÀ»ýº´¿ø) 
Åä·Ð 09-04 ¿Â¶óÀΠ15:15~15:25 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ15:35~16:00 Anticholinergic Drugs and Incident Dementia, Mild Cognitive Impairment and Cognitive Decline  À±¼­¿µ(´ë±¸°¡Å縯ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ16:00~16:25 Psychosis in Neurodegenerative Disease: Differential Patterns of Hallucination and Delusion Symptoms  Àüµ¿¿í(ÀÎÁ¦ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ16:25~16:50 Opportunities and possibilities of new monoclonal antibody drugs in the treatment of Alzheimer  ÀÌ¿µ¹Î(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ16:50~17:00 ÁúÀÇ ¹× Åä·Ð  () 
Åä·Ð 09-04 ¿Â¶óÀΠ09:40~10:05 Research domain criteria  ±è°æ¿ø(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ10:05~10:30 Endophenotypes in psychiatric illness  ¼­ÇýÁø(¿ëÀÎÁ¤½Åº´¿ø) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ10:30~10:55 Artificial intelligence and the future of psychiatry  ¼ÛÁØ¿µ(KAIST) 
Åä·Ð 09-04 ¿Â¶óÀΠ10:55~11:05 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ11:15~11:40 Current neuroimaging techniques in dementia  ±èÇý±Ý(¿µ³²ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ11:40~12:05 Biomarkers and endophenotypes of dementia  ±èº´¼ö(°æºÏÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ12:05~12:30 Current and future treatments in dementia  ÀÌÁ¤Àç(´Ü±¹ÀÇ´ë) 
Åä·Ð 09-04 ¿Â¶óÀΠ12:30~12:40 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ12:40~13:40 Role of bupropion in MDD patients  ±è¾çÅÂ(°è¸íÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ14:00~14:25 Assessment and diagnosis of PTSD  °­Å¿í(À»ÁöÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ14:25~14:50 Pathophysiology and endophenotypes of PTSD  Á¤¿ì¿µ(¾ç»êºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ14:50~15:15 Evidence based treatments for PTSD  Á¤¼º¿ø(°è¸íÀÇ´ë) 
Åä·Ð 09-04 ¿Â¶óÀΠ15:15~15:25 ÁúÀÇ ¹× Åä·Ð  () 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ15:35~16:00 Endophenotypes of depression  Á¤ÈñÁ¤(ºÎ»êÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ16:00~16:25 Neuromodulation for depression  ¿ÀÁÖ¿µ(¿¬¼¼ÀÇ´ë) 
±³À°½Ã°£ 09-04 ¿Â¶óÀΠ16:25~16:50 Digital healthcare technology in depression  Á¶µ¿·¡(µö¸Þµð) 
Åä·Ð 09-04 ¿Â¶óÀΠ16:50~17:00 ÁúÀÇ ¹× Åä·Ð  () 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" 2021³â ´ëÇÑ»ý¹°Ä¡·áÁ¤½ÅÀÇÇÐȸ Ãß°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2021-09-04""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇÑ´ëÀåÇ×¹®ÇÐȸ (¿Â¶óÀÎ) International Colorectal Research Summit 2021 (2ÀÏÂ÷) : 2021-09-04
´ÙÀ½±Û ´ëÇѽÉÇ÷°üÁßÀçÇÐȸ The 14th K-TRI Workshop : 2021-09-04
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20507 ºÎ»ê ´ëÇÑÁ¤Çü¿Ü°ú ºÎ»ê․¿ï»ê․°æ³²Áöȸ Á¦361Â÷ ¿ù·ÊÇмúȸ : 2024-05-14 0 94 2024-04-29
20506 ¼­¿ï ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ 2024 Áöȸ½ÉÆ÷Áö¾ö-¼­¿ï(°­³²) : 2024-05-14 0 101 2024-04-29
20505 °æ±â ÇѸ²´ëÇб³¼º½Éº´¿ø Æó ¿¬¼ö°­Á : 2024-05-14 0 95 2024-04-29
20504 ¼­¿ï (1ÀÏÂ÷) ´ëÇÑÁø´Ü°Ë»çÀÇÇÐȸ 2024³â Ãá°è½ÉÆ÷Áö¾ö : 2024-05-13 0 66 2024-04-29
20503 ´ëÀü Çѱ¹¿©ÀÚÀÇ»çȸ ´ëÀüÁöȸ 5¿ù Çмú½ÉÆ÷Áö¾ö(¾î±ú ÅëÁõÀÇ ¿øÀΰú Ä¡·á) : 2024-05-13 0 55 2024-04-29
20502 °æ±â (¿Â¶óÀÎ) Á¦1Â÷ ±ºÆ÷½ÃÀÇ»çȸ Çмú´ëȸ : 2024-05-12 0 115 2024-04-29
20501 ¼­¿ï Á¦12ȸ ´ëÇÑÀÓ»ó¼øȯ±âÇÐȸ Ãá°èÇмú´ëȸ : 2024-05-12 0 72 2024-04-29
20500 ¼­¿ï 2024 Á¦2Â÷ ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸºÎÀοµ»ó¿¬±¸ Çмú´ëȸ ¹× ¿¬¼ö°­Á : 2024-05-12 0 79 2024-04-29
20499 ¼­¿ï Çѱ¹Á¤½ÅÄ¡·áÇÐȸ Á¤½ÅÄ¡·á Áõ·Ê¹ßÇ¥ : 2024-05-11 0 116 2024-04-29
20498 ºÎ»ê ¸¸¼ºÆó¼â °ü»óµ¿¸Æ ÁßÀç½Ã¼ú¿¬±¸È¸ The 23rd K-CTO(Korean Chronic Total Occlusion Club) Live Demonstration : 2024-05-11 0 80 2024-04-29
20497 ¼­¿ï ´ëÇÑÀü¸³¼±ÇÐȸ The 3rd Korean Prostate Society Prostate Cancer Working Group Symposium : 2024-05-11 0 120 2024-04-29
20496 ¼­¿ï 2024 ´ëÇÑõ½Ä¾Ë·¹¸£±âÇÐȸ Ãá°èÇмú´ëȸ(2ÀÏÂ÷) : 2024-05-11 0 54 2024-04-29
20495 ¼­¿ï Á¦77Â÷ ´ëÇÑû°¢ÇÐȸ Çмú´ëȸ : 2024-05-11 0 111 2024-04-29
20494 ÀÎõ Á¦9ȸ °¡Ãµ´ë ±æº´¿ø ½Å°æ¿Ü°ú ¾÷µ¥ÀÌÆ® ½ÉÆ÷Áö¿ò (G-NeUS) : 2024-05-11 0 107 2024-04-29
20493 ´ëÀü 2024³â ´ëÇѽŰæÁßÀçÄ¡·áÀÇÇÐȸ Ãá°èÇмú´ëȸ & Basic Training Course : 2024-05-11 0 89 2024-04-29
41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷